BALCX
Price
$38.19
Change
+$0.10 (+0.26%)
Updated
Sep 26 closing price
Net Assets
262.04B
DBOCX
Price
$25.38
Change
+$0.10 (+0.40%)
Updated
Sep 26 closing price
Net Assets
286.54M
Interact to see
Advertisement

BALCX vs DBOCX

Header iconBALCX vs DBOCX Comparison
Open Charts BALCX vs DBOCXBanner chart's image
American Funds American Balanced C
Price$38.19
Change+$0.10 (+0.26%)
VolumeN/A
Net Assets262.04B
BNY Mellon Balanced Opportunity C
Price$25.38
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets286.54M
BALCX vs DBOCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. DBOCX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and DBOCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 262B vs. DBOCX (287M). BALCX pays higher dividends than DBOCX: BALCX (1.16) vs DBOCX (0.40). BALCX was incepted earlier than DBOCX: BALCX (25 years) vs DBOCX (22 years). DBOCX (2.03) is less costly to investors than BALCX (1.31). DBOCX (46.25) and BALCX (44.00) have comparable annual turnover. BALCX has a lower initial minimum investment than DBOCX: BALCX (250) vs DBOCX (1000). BALCX annual gain was more profitable for investors over the last year : 7.00 vs. DBOCX (3.07). BALCX return over 5 years is better than : 39.74 vs. DBOCX (11.82).
BALCXDBOCXBALCX / DBOCX
Total Expense Ratio1.311.9069%
Annual Report Gross Expense Ratio1.312.0365%
Fund Existence25 years22 years-
Gain YTD12.2738.173150%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets262B287M91,289%
Annual Yield % from dividends1.160.40288%
Returns for 1 year7.003.07228%
Returns for 3 years47.8631.57152%
Returns for 5 years39.7411.82336%
Returns for 10 years74.2128.98256%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDI1.560.11
+7.59%
Calidi Biotherapeutics
VTGN3.520.15
+4.30%
VistaGen Therapeutics
TCBX39.410.40
+1.03%
Third Coast Bancshares
EWBC108.410.50
+0.46%
East West Bancorp
WAFD30.940.13
+0.42%
WaFd